Minodronate for glucocorticoid induced osteoporosis versus alfacalcidol

Trial Profile

Minodronate for glucocorticoid induced osteoporosis versus alfacalcidol

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Minodronic acid (Primary) ; Alfacalcidol
  • Indications Corticosteroid-induced osteoporosis
  • Focus Therapeutic Use
  • Acronyms m-GLORIA
  • Most Recent Events

    • 20 Jun 2016 Status changed from recruiting to active, no longer recruiting.
    • 12 Feb 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 24 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top